Skip to main content

Table 1 Characteristics of uRM patients in the control and immunotherapy groups

From: Low-dose lymphocyte immunotherapy rebalances the peripheral blood Th1/Th2/Treg paradigm in patients with unexplained recurrent miscarriage

 

Control group

Immunotherapy group

p value

Total number

35

64

 

Maternal age (years)

30.23 ± 4.98

30.89 ± 4.44

0.498

Number of miscarriages

2.23 ± 0.43

2.41 ± 0.68

0.166

Th1 cell proportion (%)

27.15 ± 9.00

30.02 ± 9.88

0.157

Th2 cell proportion (%)

0.96 ± 0.58

0.89 ± 0.39

0.478

Treg cell proportion (%)

2.16 ± 0.73

1.95 ± 0.74

0.174